Telomere Shortening and Haemodialysis
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Increased oxidative stress is a well described feature of haemodialysis (HD). This is secondary to an increase in the production of reactive oxygen species and impaired antioxidant mechanisms. Telomeres are the specialized ends of eukaryotic chromosomes and consist of tandemly repeated DNA sequences. Telomeres shorten with each cell division and it is well known that telomere length in peripheral blood mononuclear cells (PBMCs) decreases with age. Telomere shortening rate is increased by oxidative stress. In this study we have examined a possible relationship between oxidative stress and telomere shortening in haemodialysis. METHODS: 20 control subjects, 20 non-diabetic and 18 diabetic HD patients were studied. Peripheral blood mononuclear cell telomere length, plasma malondialdehyde plus 4-hydroxyalkenal (MDA+4-HAE) concentration (a marker of oxidative stress) and C-reactive protein (CRP) concentration were measured. RESULTS: MDA+4-HAE and CRP were significantly higher in the HD patients (CRP, controls 7.5 +/- 1.5, HD patients 16.4 +/- 3.1 mg/l, p < 0.05). There was no difference in mean telomere length between the HD patients and controls (control, 8,283 +/- 179 bp; non-diabetic HD, 7,966 +/- 160 bp; diabetic HD, 8,033 +/- 197 bp) but age adjusted residual telomere length was inversely associated with the length of time on dialysis (r = -0.35, p = 0.03). CONCLUSION: These results suggest that length of time on dialysis is independently associated with increased telomere shortening in HD patients. We hypothesise that this reflects cumulative DNA exposure to oxidative stress.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, an inverse correlation with the length of telomeres was shown for the development of cardiovascular disease [44-47], renal failure [48, 49], various cancers [50, 51], Alzheimer's disease [52], and Parkinson's disease [53].”
From Markers of cellular senescence. Telomere shortening as a marker of cellular senescence (2016) · cites this paper as [49]
Citations
Cites
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672 · cited 1×
“In this study we have explored a possible relationship between oxidative stress and telomere shortening in haemodialysis. Methods 38 haemodialysis patients (18 diabetic and 20 non-diabetic patients) and 20 age- and sex-matched locally recruited normal subjects were studied. The length of time on dialysis was measured…”
MethodTelomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Accelerated telomere shortening in response to life stress
Epel, E. S., Blackburn, E. H., Lin, J., Dhabhar, F. S., Adler, N. E., Morrow, J. D., & Cawthon, R. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407162101 · Cited by 3,002
Oxidative stress shortens telomeres
von Zglinicki, T. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)02110-2 · Cited by 2,524
DNA damage and oxygen radical toxicity
Imlay, J. A., & Linn, S. (1988) · Science · doi:10.1126/science.3287616 · Cited by 1,974 · cited 1×
“Oxidative stress can cause damage to many macromolecules including lipids, protein and DNA [”
BackgroundOlovnikov (1973) · doi:10.1016/0022-5193(73)90198-7 · Cited by 1,847 · cited 1×
“This is due in part to the inability of chromosomes to completely replicate to their ends, the so called ‘end replication problem’ [”
BackgroundAssociation between telomere length in blood and mortality in people aged 60 years or older
Cawthon, R. M., Smith, K. R., O'Brien, E., Sivatchenko, A., & Kerber, R. A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12384-7 · Cited by 1,761 · cited 1×
“In humans the telomere length of peripheral blood mononuclear cells (PBMCs) decreases with age [ , , ,”
BackgroundEvidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age.
Vaziri, H., Dragowska, W., Allsopp, R. C., Thomas, T. E., Harley, C. B., & Lansdorp, P. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9857 · Cited by 1,132 · cited 1×
“Some studies have indicated that MDA+4-HAE are removed by dialysis [ , ,”
BackgroundOberg, B. P., McMenamin, E., Lucas, F. L., McMonagle, E., Morrow, J., Ikizler, T. A. L. P., & Himmelfarb, J. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00465.x · Cited by 781
Rufer, N., Brümmendorf, T. H., Kolvraa, S., Bischoff, C., Christensen, K., Wadsworth, L., Schulzer, M., & Lansdorp, P. M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.2.157 · Cited by 709 · cited 1×
“PBMC telomere shortening rates have been reported to be higher in young children [”
Background
Cited by
Renal Aging: Causes and Consequences
O’Sullivan, E. D., Hughes, J., & Ferenbach, D. A. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015121308 · Cited by 484
A systematic review of leukocyte telomere length and age in adults
Müezzinler, A., Zaineddin, A. K., & Brenner, H. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.01.003 · Cited by 474
Markers of cellular senescence. Telomere shortening as a marker of cellular senescence
Bernadotte, A., Mikhelson, V. M., & Spivak, I. M. (2016) · Aging · doi:10.18632/aging.100871 · Cited by 466
“Additionally, an inverse correlation with the length of telomeres was shown for the development of cardiovascular disease [44-47], renal failure [48, 49], various cancers [50, 51], Alzheimer's disease [52], and Parkinson's disease [53].”
BackgroundMechanisms of vascular calcification in CKD—evidence for premature ageing?
Shanahan, C. M. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.176 · Cited by 205
Carrero, J. J., Stenvinkel, P., Fellström, B., Qureshi, A. R., Lamb, K., Heimbürger, O., Bárány, P., Radhakrishnan, K., Lindholm, B., Soveri, I., et al. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01890.x · Cited by 186
Genetic Susceptibility to Chronic Kidney Disease – Some More Pieces for the Heritability Puzzle
Cañadas‐Garre, M., Anderson, K., Cappa, R., Skelly, R., Smyth, L. J., McKnight, A. J., & Maxwell, A. P. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00453 · Cited by 128
“Premature telomere shortening is associated with duration of dialysis treatment in terms of months to years (Boxall et al., 2006).”
BackgroundStatins, inflammation and kidney disease
Krane, V., & Wanner, C. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.62 · Cited by 91
Oxidative DNA damage in chronic renal failure patients
Stoyanova, E., Sandoval, S. B., Zúñiga-Venegas, L. A., Yamani, N. E., Coll, E., Pastor, S., Reyes, J., Andrés, E., Ballarín, J., Xamena, N., et al. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp575 · Cited by 60
“Genomic instability has also been associated with the greater telomere shortening observed in uraemic patients [38].”
BackgroundTsirpanlis, G. I. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.07.035 · Cited by 59
Wu, C.-H., Hsieh, S.-C., Li, K.-J., Lu, M.-C., & Yu, C.-L. (2007) · Lupus · doi:10.1177/0961203307077155 · Cited by 47
n-3 Fatty Acid Supplementation and Leukocyte Telomere Length in Patients with Chronic Kidney Disease
Barden, A. E., O’Callaghan, N. J., Burke, V., Mas, E., Beilin, L. J., Fenech, M. F., Irish, A. B., Watts, G. F., Puddey, I. B., Huang, R., et al. (2016) · Nutrients · doi:10.3390/nu8030175 · Cited by 51
“Patients receiving haemodialysis have shorter telomeres and accelerated telomere shortening compared with the general population [4,5].”
BackgroundTelomere attrition, kidney function, and prevalent chronic kidney disease in the United States
Mazidi, M., Rezaie, P., Covic, A. C., Małyszko, J., Rysz, J., Kengne, A. P., & Banach, M. (2017) · Oncotarget · doi:10.18632/oncotarget.20706 · Cited by 44
“The limited existing evidence suggest that patients with end-stage renal disease (ESRD) may have shorter telomere and accelerated telomere shortening compared with the general population [14, 15].”
BackgroundAssociation between Kidney Function and Telomere Length: The Heart and Soul Study
Bansal, N., Whooley, M. A., Regan, M. C., McCulloch, C. E., Ix, J. H., Epel, E. S., Blackburn, E. H., Lin, J., & Hsu, C. (2012) · American Journal of Nephrology · doi:10.1159/000343495 · Cited by 45
“Clinical studies have reported that patients with end-stage renal disease (ESRD) may have shorter telomere length and accelerated telomere shortening compared with the general population.[4,5] Studies of severe heart failure patients have reported a strong correlation between reduced kidney function and shorter telome…”
BackgroundResultT-cell ageing in end-stage renal disease patients: Assessment and clinical relevance
Meijers, R. W. J., Betjes, M. G., Baan, C. C., & Litjens, N. H. (2014) · World Journal of Nephrology · doi:10.5527/wjn.v3.i4.268 · Cited by 39
Telomere Attrition in Chronic Kidney Diseases
Levstek, T., & Podkrajšek, K. T. (2023) · Antioxidants · doi:10.3390/antiox12030579 · Cited by 30
“TLs of leukocytes and PBMCs were found to be inversely related to the duration of HD [51,53,58,60].”
BackgroundResultSandoval, S. B., Stoyanova, E., Coll, E., Pastor, S., Reyes, J. R., Andrés, E., Ballarín, J., Xamena, N., & Marcos, R. (2010) · Mutagenesis · doi:10.1093/mutage/geq047 · Cited by 28
Genomic damage as a biomarker of chronic kidney disease status
Corredor, Z., Stoyanova, E., Rodríguez‐Ribera, L., Coll, E., Silva, I., Díaz, J. M., Ballarín, J., Marcos, R., & Pastor, S. (2014) · Environmental and Molecular Mutagenesis · doi:10.1002/em.21911 · Cited by 31
Genomic instability in chronic renal failure patients
Sandoval, S. B., Pastor, S., Stoyanova, E., Rodríguez‐Ribera, L., García-Quispes, W. A., Coll, E., Reyes, J. R., Enrique, A., Ballarín, J., & Marcos, R. (2012) · Environmental and Molecular Mutagenesis · doi:10.1002/em.21694 · Cited by 31
“This genomic instability is ascribed to defective ability to repair DNA lesions, and it has already been observed in CRF patients by using different methodological approaches [Friedman et al., 1988; Zevin et al., 1991; Malachi et al., 1993; Vam- vakas et al., 1998; Boxall et al., 2006].”
MethodImpact of Oxidative Stress in Premature Aging and Iron Overload in Hemodialysis Patients
Murillo-Ortiz, B. O., Ramírez-Emiliano, J., Vázquez, W. I. H., Martínez-Garza, S., Solorio, S., Albarrán-Tamayo, F., Ramos-Rodríguez, E., & Bribiesca, L. B. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/1578235 · Cited by 27
“suggest that the length of time on dialysis is independently associated with increased telomere shortening in HD patients and hypothesize that this is caused by the cumulative exposure of DNA to oxidative stress [12].”
BackgroundStefanidis, I., Voliotis, G., Papanikolaou, V., Chronopoulou, I., Eleftheriadis, T., Kowald, A., Zintzaras, E., & Tsezou, A. (2015) · Artificial Organs · doi:10.1111/aor.12453 · Cited by 20
Renal aging and its consequences: navigating the challenges of an aging population
Zhang, M., Ni, H.-F., Lin, Y., Wang, K., He, T., Lan, Y., Han, Z., & Zuo, X. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1615681 · Cited by 29
Telomere length, telomerase activity, stress, and aging
Im, S., Mikhelson, V. M., & Spivak, D. L. (2016) · Advances in Gerontology · doi:10.1134/s2079057016010136 · Cited by 19
Hill, C., Duffy, S., Kettyle, L. M., McGlynn, L. M., Sandholm, N., Salem, R. M., Thompson, A., Swan, E. J., Kilner, J., Rossing, P. R., et al. (2023) · Genes · doi:10.3390/genes14051029 · Cited by 16
Rapamycin safeguards lymphocytes from DNA damage accumulation in vivo
Chebel, A., Catallo, R., Mabon, C., Bachy, E., Wenner, T., Salles, G. A., Pouteil‐Noble, C., & Ffrench, M. (2016) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2016.06.004 · Cited by 14
Zhang, W., Jia, L., Ma, J., Zhu, S.-Y., Nie, S., Song, K., Liu, X., Zhang, Y., Cao, D., Yang, X., et al. (2017) · The journal of nutrition health & aging · doi:10.1007/s12603-017-0905-4 · Cited by 14
“For example, the software for calculating the TRF length from results of Southern blotting, include quantitative Bio-Rad Imaging Densitometer Model GS-670 (7), Image Gauge software (29), Aida software (30), and Quantity One® 1-”
Zsom, L., Zsom, M., Fülöp, T., Wells, C., Flessner, M. F., Eller, J., Wollheim, C., Hegbrant, J., & Strippoli, G. F. (2010) · Blood Purification · doi:10.1159/000314648 · Cited by 12
Oxidative DNA Damage Is Elevated in Renal Patients Undergoing Haemodialysis
Moffitt, T., Hariton, F., Devlin, M., Garrett, P., & Hannon-Fletcher, M. P. A. (2014) · Open Journal of Preventive Medicine · doi:10.4236/ojpm.2014.46049 · Cited by 10
“HD treatment status has also been associated with greater telomere shortening, reflecting cumulative DNA exposure to oxidative stress [24].”
BackgroundPykhtina, V. S., Strazhesko, I. D., Tkacheva, O. N., Akasheva, D. U., Dudinskaya, Е. N., Vygodin, V. A., Владимировна, П. Е., Сергеевна, К. А., & Boytsov, S. A. (2016) · Advances in Gerontology · doi:10.1134/s2079057016030097 · Cited by 8
The leukocyte telomere length, single nucleotide polymorphisms near TERC gene and risk of COPD
Tacheva, T., Zienolddiny, S., Dimov, D., Vlaykova, D., & Vlaykova, T. I. (2021) · PeerJ · doi:10.7717/peerj.12190 · Cited by 9
“, 2011), renal failure (Boxall et al., 2006), various cancers (Broberg et al.”
BackgroundTelomere shortening in patients on long‐term hemodialysis
Wang, Y., Chen, S., Feng, S., Wang, C., Jiang, H., Rong, S., Haller, H. G., Chen, J., & Zhang, P. (2021) · Chronic Diseases and Translational Medicine · doi:10.1016/j.cdtm.2021.07.003 · Cited by 8
Tung, G. K., & Gandhi, G. (2023) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-023-04720-4 · Cited by 6
“Tel-omere shortening, reflecting a cumulative DNA exposure to oxidative stress, has also been observed in uremic patients [66].”
Telomere Biology Alterations as a Mortality Risk Factor in CKD
Carrero, J. J., Shiels, P. G., & Stenvinkel, P. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.02.367 · Cited by 4
Taheri, M. A., Amani, L., Nabavi, N., وزیری, ع. ز., & Khalili, A. (2022) · The Scientific Journal of Cosmointel · doi:10.61450/joci.v1i6.56 · Cited by 2
Is End-Stage Renal Disease Tumor Suppressive? Dispelling the Myths
Migita, T. (2024) · Cancers · doi:10.3390/cancers16183135 · Cited by 1
“Patients with ESRD show reduced telomerase activity or telomere attrition compared with those in the general population; this tendency is evident in patients undergoing long-term dialysis [48].”
BackgroundZhang, Y., Zhang, C., He, P., Tian, X., Kong, Y., & Zhou, Y. (2025) · International Urology and Nephrology · doi:10.1007/s11255-025-04481-7 · Cited by 2
“Moreover, premature telomere shortening was independently linked to the duration of dialysis treat-ment [37].”
(2021) · PeerJ · doi:10.7287/peerj.12190v0.1/reviews/1
“…conditions such as atherosclerosis, diabetes type I (Houben et al. 2009) cardiovascular disease (Fitzpatrick et al. 2011), renal failure (Boxall et al. 2006), various cancers (Broberg et al. 2005), Alzheimer's disease (Cai et al. 2013), and Parkinson's disease (Maeda et al. 2012) have…”
تأثیر میدان شعوری فرادرمانی بر تکثیر، فعالیت آنزیم تلومراز و طول تلومر سلولهای بنیادی مزانشیمی انسان
طاهری, م. ع., امانی, ل., نبوی, ن., وزیری, ع. ز., & خلیلی, ا. (2022) · ژورنال علمی کازمواینتل · doi:10.61450/joci.fa.v1i6.116
Introductory background to telomere shortening
Mantle, D. (2025) · Journal of Kidney Care · doi:10.12968/jokc.2025.0013
Duraiswamy, A., Jagadeesan, K., & Aruna, P. (2026) · Discover Medicine · doi:10.1007/s44337-026-00674-w
“Dialysis patients demonstrate accelerated telomere attrition reflecting cumulative oxidative stress and inflammation [10].”
Metadata
- Authors
- Boxall, M. C., Goodship, T. H. J., Brown, A. L., Ward, M. C., & von Zglinicki, T.
- Affiliations
- Newcastle upon Tyne Hospitals NHS Foundation Trust (GB)
- Venue
- Blood Purification
- Publisher
- S. Karger AG
- Published
- 2006
- Volume
- 24
- Issue
- 2
- Pages
- 185-189
- ISSN
- 0253-5068 (ISSN-L)
- 1421-9735
- OpenAlex
- W2023535913
- Cited by
- 41
- References
- 43
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 1 · 2023: 3 · 2022: 2 · 2021: 5 · 2019: 1 · 2017: 2 · 2016: 7 · 2015: 1 · 2014: 3 · 2013: 2 · 2012: 2
- FWCI
- 0.80
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Blood Purification (publishedVersion)
- PubMed (publishedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Wellcome Trust
- Northern Counties Kidney Research Fund
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Keywords
- telomere shortening, hemodialysis, oxidative stress, reactive oxygen species, malondialdehyde, 4-hydroxyalkenals, C-reactive protein, peripheral blood mononuclear cells, dialysis duration, diabetes mellitus, chronic kidney disease
- MeSH terms
- Aldehydes, C-Reactive Protein, Female, Renal Dialysis, Humans, Male, Malondialdehyde, Middle Aged, Predictive Value of Tests, Telomere, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.